Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peripheral blood myeloperoxidase activity increases during hemodialysis.

Literature DB >> 12846778

Peripheral blood myeloperoxidase activity increases during hemodialysis.

Abraham Rutgers, Peter Heeringa, Jeroen P Kooman, Frank M van der Sande, Jan Willem Cohen Travaert.

Abstract

Mesh：

Substances：
Peroxidase

Year: 2003 PMID： 12846778 DOI： 10.1046/j.1523-1755.2003.00139.x

Source DB: PubMed Journal: Kidney Int ISSN： 0085-2538 Impact factor: 10.612

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Effect of Hemodialysis on Plasma Myeloperoxidase Activity in End Stage Renal Disease Patients.

Authors: A Madhusudhana Rao; R Apoorva; Usha Anand; C V Anand; G Venu
Journal: Indian J Clin Biochem Date: 2012-03-24

2. Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins.

Authors: M C Slot; R Theunissen; P van Paassen; J G M C Damoiseaux; J W Cohen Tervaert
Journal: Clin Exp Immunol Date: 2007-05-22 Impact factor: 4.330

3. Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function management.

Authors: Renata P Assis; Juliana F A Castro; Vânia O Gutierres; Carlos A Arcaro; Renata S Brotto; Olga M M F Oliveira; Amanda M Baviera; Iguatemy L Brunetti
Journal: BMC Nephrol Date: 2015-04-11 Impact factor: 2.388

Review 4. Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins.

Authors: Nans Florens; Catherine Calzada; Egor Lyasko; Laurent Juillard; Christophe O Soulage
Journal: Toxins (Basel) Date: 2016-12-16 Impact factor: 4.546

5. Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.

Authors: Cédric Delporte; Karim Zouaoui Boudjeltia; Caroline Noyon; Paul G Furtmüller; Vincent Nuyens; Marie-Christine Slomianny; Philippe Madhoun; Jean-Marc Desmet; Pierre Raynal; Damien Dufour; Chintan N Koyani; Florence Reyé; Alexandre Rousseau; Michel Vanhaeverbeek; Jean Ducobu; Jean-Claude Michalski; Jean Nève; Luc Vanhamme; Christian Obinger; Ernst Malle; Pierre Van Antwerpen
Journal: J Lipid Res Date: 2014-02-17 Impact factor: 5.922

Peripheral blood myeloperoxidase activity increases during hemodialysis.

1. Effect of Hemodialysis on Plasma Myeloperoxidase Activity in End Stage Renal Disease Patients.

2. Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins.

3. Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function management.

Review 4. Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins.

5. Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.

Review 6. Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Review 7. Role of Myeloperoxidase in Patients with Chronic Kidney Disease.

8. Association between MPO-463G > A polymorphism and chronic kidney disease: a meta-analysis.